Methods of treating behavior alterations
A behavioral, purposeful technology, applied in the field of therapeutic behavioral change, that addresses unmet problems
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 5
[0047] Example 5 and Figure 5 and Image 6 The utility of KDM1A inhibitors for the treatment of social behavior changes is further illustrated using another widely used social behavior test, the three-compartment test (TCT). TCT is a common method for measuring social behavior in mice and can be used to assess the effects of compound treatments for altered social interaction using animals that exhibit congenital or acquired deficits in social behavior. In the TCT test, as described in more detail in Example 5, after acclimation to the three-chamber arena, mice were released into the middle chamber and allowed to explore the other chambers. In the adjacent "mouse" compartment, a docile stimulus mouse was located in a mesh container, while a similar container was in the other adjacent compartment without stimulation mice (target compartment). The tendency of mice to approach or avoid compartments with stimulation provided a measure of sociability. as in Example 5 and Figur...
Embodiment 1
[0323] Example 1: Materials
[0324] Compound 1 (or Comp.1) is compound 5-((((1R,2S)-2-(4-(benzyloxy)phenyl)cyclopropyl)amino)methyl)-1,3,4- Oxadiazol-2-amine, also known as (-)5-(((((trans)-2-(4-(benzyloxy)phenyl)cyclopropyl)amino)methyl)-1, 3,4-oxadiazol-2-amine, the chemical structure of which is shown below.
[0325]
[0326] This compound can be obtained as disclosed in WO2012 / 013728.
Embodiment 2
[0327] Example 2: In vitro KDM1A inhibition assay
[0328] The inhibitory activity of compounds against KDM1A can be determined using the following methods.
[0329] Human recombinant KDM1A protein (GenBank accession number NM_015013, amino acid 158 terminus with N-terminal GST tag, MW: 103 kDa) was used.
[0330] Serial 3-fold dilutions of test compounds (ranging between 30 μM and 1 nM) were pre-incubated with human recombinant KDM1A enzyme (BPS Bioscience, reference 50100) in assay buffer (50 mM sodium phosphate pH 7.4) for 15 min on ice . Each concentration of inhibitor was tested in duplicate. Via appK in KDM1A M Dimethyl H3K4 peptide substrate (Anaspec, ref. 63677) was added to initiate the enzymatic reaction. After 30 min incubation at 37°C, Amplex red reagent and horseradish peroxidase (HRP) solution were added as recommended by the supplier (Invitrogen) to detect H formed in the enzymatic reaction 2 O 2 . The mixture was incubated for 5 minutes at room tempera...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



